Regeneron Pharmaceuticals Inc - Mammoth Is Eligible to Receive up to $370 Mln per Target in Development, Regulatory and Commercial Milestone Payments
Regeneron Pharmicals Inc-Mammoth 有資格爲每個目標獲得高達3.7億美元的開發、監管和商業里程碑付款
Regeneron Pharmaceuticals Inc - Mammoth Is Eligible to Receive up to $370 Mln per Target in Development, Regulatory and Commercial Milestone Payments
Regeneron Pharmicals Inc-Mammoth 有資格爲每個目標獲得高達3.7億美元的開發、監管和商業里程碑付款
使用瀏覽器的分享功能,分享給你的好友吧